0001193125-24-003951.txt : 20240108 0001193125-24-003951.hdr.sgml : 20240108 20240108081532 ACCESSION NUMBER: 0001193125-24-003951 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240108 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: eFFECTOR Therapeutics, Inc. CENTRAL INDEX KEY: 0001828522 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853306396 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39866 FILM NUMBER: 24518458 BUSINESS ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 BUSINESS PHONE: (858) 925-8215 MAIL ADDRESS: STREET 1: 142 NORTH CEDROS AVENUE, SUITE B CITY: SOLANA BEACH STATE: CA ZIP: 92075 FORMER COMPANY: FORMER CONFORMED NAME: Locust Walk Acquisition Corp. DATE OF NAME CHANGE: 20201015 8-K 1 d109452d8k.htm 8-K 8-K
false 0001828522 0001828522 2024-01-08 2024-01-08 0001828522 eftr:CommonStock0.0001ParValuePerShare2Member 2024-01-08 2024-01-08 0001828522 eftr:WarrantsToPurchaseCommonStock1Member 2024-01-08 2024-01-08

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 8, 2024

 

 

eFFECTOR Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39866   85-3306396
(State or other jurisdiction
of incorporation)		   (Commission
File Number)		   (I.R.S. Employer
Identification No.)

 

142 North Cedros Avenue, Suite B

Solana Beach, California

   92075
(Address of principal executive offices)   (Zip Code)

(858) 925-8215

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading

Symbol(s)

  

Name of each exchange
on which registered

Common stock, $0.0001 par value per share   EFTR   Nasdaq Capital Market
Warrants to purchase common stock   EFTRW   Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Sec.230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Sec.240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 2.02 Results of Operations and Financial Condition.

eFFECTOR Therapeutics, Inc. (the “Company”) expects to report that its cash, cash equivalents and short-term investments as of December 31, 2023 were approximately $18.4 million. In addition, the Company now anticipates that its existing cash, cash equivalents and short-term investments will fund its operations into the third quarter of 2024, whereas the Company had previously estimated that its existing cash, cash equivalents and short-term investments would fund operations into the second quarter of 2024.

The Company has not yet completed its quarter-end financial close process for the quarter ended December 31, 2023. This estimate of the Company’s cash, cash equivalents and short-term investments as of December 31, 2023 is preliminary, has not been audited and is subject to change upon completion of the Company’s financial statement closing procedures. Additional information and disclosure would be required for a more complete understanding of the Company’s financial position and results of operations as of December 31, 2023. The Company’s independent registered public accounting firm has not audited, reviewed or performed any procedures with respect to this preliminary result and, accordingly, does not express an opinion or any other form of assurance about it.

The Company cautions you that statements contained in this report regarding matters that are not historical facts are forward-looking statements. The forward-looking statements are based on the Company’s current beliefs and expectations and include, but are not limited to the sufficiency of the Company’s capital resources to fund operations into the third quarter of 2024. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in our business, including, without limitation: the Company may use its capital resources sooner than expected and other risks described in the Company’s prior filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

The information contained in this Current Report on Form 8-K under Item 2.02 is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and will not be incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, unless specifically identified as being incorporated therein by reference.

Item 7.01 Regulation FD Disclosure.

On January 8, 2024, the Company provided an update to its corporate presentation by posting the presentation to the Company’s website, www.effector.com. The Company plans to use its website to disseminate future updates to its corporate presentation and does not intend to file or furnish a Form 8-K alerting investors each time the presentation is updated.

The information set forth in this Item 7.01 is being furnished pursuant to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, and it shall not be deemed incorporated by reference in any filing under the Securities Act, or under the Exchange Act, whether made before or after the date hereof, except as expressly provided by specific reference in such a filing.

By filing this Current Report on Form 8-K and furnishing the information in this Item 7.01, the Company makes no admission as to the materiality of Item 7.01 in this report or the presentation available on the Company’s website. The information contained in the corporate presentation is summary information that is intended to be considered in the context of the Company’s filings with the Securities and Exchange Commission (the “SEC”) and other public announcements that the Company makes, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this Current Report on Form 8-K, although it may do so from time to time as its management believes is appropriate or as required by applicable law. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases, by updating its website or through other public disclosure.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    eFFECTOR Therapeutics, Inc.
Date: January 8, 2024     By:  

/s/ Michael Byrnes

    Name:   Michael Byrnes
    Title:   Chief Financial Officer
 EX-101.SCH 2 eftr-20240108.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.DEF 3 eftr-20240108_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 4 eftr-20240108_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Document And Entity Information [Table] Document And Entity Information [Table] Document And Entity Information [Line Items] Document And Entity Information [Line Items] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock 0.0001 Par Value Per Share 2 [Member] Common Stock 0.0001 Par Value Per Share 2 [Member] Warrants To Purchase Common Stock 1 [Member] Warrants To Purchase Common Stock 1 [Member] EX-101.PRE 5 eftr-20240108_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Document and Entity Information
Jan. 08, 2024
Document And Entity Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001828522
Document Type 8-K
Document Period End Date Jan. 08, 2024
Entity Registrant Name eFFECTOR Therapeutics, Inc.
Entity Incorporation State Country Code DE
Entity File Number 001-39866
Entity Tax Identification Number 85-3306396
Entity Address, Address Line One 142 North Cedros Avenue
Entity Address, Address Line Two Suite B
Entity Address, City or Town Solana Beach
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92075
City Area Code (858)
Local Phone Number 925-8215
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Common Stock 0.0001 Par Value Per Share 2 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Common stock, $0.0001 par value per share
Trading Symbol EFTR
Security Exchange Name NASDAQ
Warrants To Purchase Common Stock 1 [Member]  
Document And Entity Information [Line Items]  
Security 12b Title Warrants to purchase common stock
Trading Symbol EFTRW
Security Exchange Name NASDAQ
XML 7 d109452d8k_htm.xml IDEA: XBRL DOCUMENT 0001828522 2024-01-08 2024-01-08 0001828522 eftr:CommonStock0.0001ParValuePerShare2Member 2024-01-08 2024-01-08 0001828522 eftr:WarrantsToPurchaseCommonStock1Member 2024-01-08 2024-01-08 false 0001828522 8-K 2024-01-08 eFFECTOR Therapeutics, Inc. DE 001-39866 85-3306396 142 North Cedros Avenue Suite B Solana Beach CA 92075 (858) 925-8215 false false false false Common stock, $0.0001 par value per share EFTR NASDAQ Warrants to purchase common stock EFTRW NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 3 24 1 false 2 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d109452d8k.htm eftr-20240108.xsd eftr-20240108_def.xml eftr-20240108_lab.xml eftr-20240108_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d109452d8k.htm": { "nsprefix": "eftr", "nsuri": "http://effector.com/20240108", "dts": { "inline": { "local": [ "d109452d8k.htm" ] }, "schema": { "local": [ "eftr-20240108.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "definitionLink": { "local": [ "eftr-20240108_def.xml" ] }, "labelLink": { "local": [ "eftr-20240108_lab.xml" ] }, "presentationLink": { "local": [ "eftr-20240108_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 31, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 27 }, "report": { "R1": { "role": "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-01-08_to_2024-01-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d109452d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-01-08_to_2024-01-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d109452d8k.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "eftr_CommonStock0.0001ParValuePerShare2Member": { "xbrltype": "domainItemType", "nsuri": "http://effector.com/20240108", "localname": "CommonStock0.0001ParValuePerShare2Member", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Stock 0.0001 Par Value Per Share 2 [Member]", "terseLabel": "Common Stock 0.0001 Par Value Per Share 2 [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "eftr_WarrantsToPurchaseCommonStock1Member": { "xbrltype": "domainItemType", "nsuri": "http://effector.com/20240108", "localname": "WarrantsToPurchaseCommonStock1Member", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Warrants To Purchase Common Stock 1 [Member]", "terseLabel": "Warrants To Purchase Common Stock 1 [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "eftr_DocumentAndEntityInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://effector.com/20240108", "localname": "DocumentAndEntityInformationTable", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Table]", "terseLabel": "Document And Entity Information [Table]" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "eftr_DocumentAndEntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://effector.com/20240108", "localname": "DocumentAndEntityInformationLineItems", "presentation": [ "http://effector.com//20240108/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document And Entity Information [Line Items]", "terseLabel": "Document And Entity Information [Line Items]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001193125-24-003951-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-003951-xbrl.zip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end